Fluence Partners with Pexapark to Accelerate the Clean Energy Transition Through Combining Advanced Market Intelligence and Energy Storage Insights
2.2.2022 09:00:00 CET | Business Wire | Press Release
Fluence (NASDAQ: FLNC), a global market leader in energy storage products and services and digital applications for renewables and storage, and Pexapark, an award-winning provider of software and advisory services for renewable energy sales and risk management, announced today they have entered into a long-term strategic partnership. The collaboration will provide customers with a powerful combination of insights required to navigate and lead through the clean energy transition.
Significant growth in energy storage and renewables, coupled with increased market volatility and regulatory changes, are making data-driven market intelligence a must-have for any market participant in the electricity sector. Fluence and Pexapark have partnered to bring together unique insights that will help investors, independent power producers (IPPs) and utilities make better decisions as they navigate merchant market risks and maximize revenues while working to advance the clean energy transition.
Under the strategic partnership, Fluence’s customers will gain access to Pexapark’s suite of analytical tools and services that simplify the complexity of energy transactions, delivering greater price transparency and risk management, while supporting industry players in their journey through project planning to long-term operations.
Combined with the advanced analytics for renewable energy generation and energy storage assets already delivered by Fluence, these sophisticated tools will enable customers to maximize the value of their investment and increase deployments.
Asset developers and owners will particularly benefit from pricing and analytics for storage and co-located facilities, advice on the best Power Purchase Agreement (PPA) structuring for specific types of generation and energy storage assets, and expert advisory on trading and hedging strategies.
“Today’s announcement is another major milestone for realizing Fluence’s ambition to develop a unique ecosystem that changes the way our customers power the world,” said Manuel Perez Dubuc, CEO of Fluence. “We are growing this ecosystem, including third-party technology solutions, with our products, services and digital applications for renewables and storage.”
“Our partnership with Pexapark will encourage greater investment in and deployment of clean energy generation and battery-based energy storage projects on the grid. Together, we will use our digital solutions to advance the global clean energy transition.”
Michael Waldner, CEO and Co-Founder, Pexapark said: “As the renewable energy sector continues to evolve – increasingly at the mercy of the merchant markets and price volatility - it is critical that industry players are armed with the data, knowledge and software to maximize their returns and manage their risks. In light of current market pricing trends, those who couple the most advanced technological solutions with the most accurate market intelligence will have the edge when it comes to increasing their revenue potential.”
“As energy storage increasingly becomes an integral part of renewables portfolios, this partnership promises to provide an immediate boost to managing the complex opportunities and risks involved.”
Advanced energy storage solutions are the critical enabling technology to achieve clean energy targets. Pexapark’s unique market knowledge and data will be paired with Fluence’s fleet of 3.6 GW of battery-based storage solutions deployed or contracted to deliver real world operational insights. The Fluence IQ Bidding Application, which uses artificial intelligence, advanced price forecasting, portfolio optimization and market bidding, will ensure energy storage and flexible generation assets are optimally participating in wholesale electricity markets.
This partnership with Pexapark is aligned with Fluence’s strategy of maintaining an open digital ecosystem that gives customers the flexibility to integrate third-party software and tools with Fluence storage and control systems. Fostering an open, horizontally integrated ecosystem that makes Fluence’s – and others’ - innovative technologies as broadly available as possible is one of the company’s goals in pursuit of its mission to enable the global clean energy transition.
About Fluence
Fluence is a global market leader in energy storage products and services, and digital applications for renewables and storage. As of September 30, 2021, the company has more than 3.6 GW of energy storage deployed or contracted in 30 markets globally, and more than 4.7 GW of wind, solar, and storage assets optimized or contracted in Australia and California. Through our products, services and AI-enabled Fluence IQ platform, Fluence is helping customers around the world drive more resilient electric grids and a more sustainable future. For more information, please visit www.fluenceenergy.com.
About Pexapark
Pexapark is an award-winning enterprise software and advisory company, specialised in renewable energy. With more than 20,000 MW of renewable PPA transactions supported, Pexapark is the reference for buying, selling and managing renewable energy.
Pexapark’s PPA reference prices increase transparency across 18 markets. Our advisory team and software suite enable leading companies to close successful PPA transactions, manage their risk and grow their renewable energy revenues.
Pexapark was founded in 2017 with the purpose of accelerating the energy transition towards net zero by creating an efficient market for renewable energy.
For more information, please visit https://pexapark.com, or get in touch with us at hello@pexapark.com
Forward-Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release are forward-looking statements, including, without limitation, expected benefits of the partnership with Pexapark, commencement of its services agreement, and the development or/and integration of Pexapark’s services and technology for use by Fluence’s customers.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Fluence’s control and are difficult to predict. Factors that may cause such differences in expected results include but are not limited to the following: Fluence may face significant barriers and delays in the integration of Pexapark’s services and technologies. Fluence caution that the foregoing list of factors is not exclusive.
Except as otherwise required by applicable law, Fluence disclaim any duty to update any forward-looking statements contained in this press release, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release. Should underlying assumptions prove incorrect, actual results and projections could differentiate materially from those expressed in any forward-looking statements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005209/en/
Contact information
Fluence Press Enquires
Joanna Spirodek
Regional Marketing Manager, EMEA
Joanna.Spirodek@fluenceenergy.com
+49 1728 662155
Pexapark Press Enquiries
Florent Petitfrere
Head of Marketing
Florent.petitfrere@pexapark.com
+41786006017
Fluence Investors
Samuel Chong
+1 872-301-2501
InvestorRelations@fluenceenergy.com
Lexington May
+1 713-909-5629
InvestorRelations@fluenceenergy.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom